Effects of Irbesartan on Atherosclerosis Lesion and NAD(P)H Oxidase in High Cholesterol-Diet Apolipoprotein E Knock-out Mice

姚瑞,程翔,廖玉华,陈勇,谢江娇,余娴,丁英俊,唐婷婷
DOI: https://doi.org/10.3321/j.issn:1001-1978.2008.10.008
2008-01-01
Abstract:Aim To investigate the potential effects of an angiotensin type 1 receptor blockers irbesartan on the atherosclerosis lesion and NAD(P)H oxidase in high cholesterol-diet (HCD) apolipoprotein E knock-out (ApoE KO) mice.Methods Adult male ApoE KO mice were given normal diet (ND) or HCD and randomized to no treatment group or irbesartan 10 mg·kg-1·d-1 for 12 weeks group. Systolic blood pressure was measured by a kind of non-invasive tail cuff system in conscious mice.The plasma total cholesterol and triglyceride concentration were measured by autoanalyzer. Atherosclerotic lesion area in aortic root was evaluated by oil red O staining. NAD(P)H oxidase subunits were measured by real-time reverse-transcription polymerase chain reaction (PCR) and Western blot.Results The ApoE KO mice with HCD was associated with a marked increase in plasma lipid levels, atherosclerotic lesion area,as well as the expressions of NAD(P)H oxidase subunits p47phox and Rac-1.These changes were suppressed in mice treated with irbesartan 10 mg·kg-1·d-1 for 12 weeks concomitant with HCD administration,with no significant change in systolic blood pressure and plasma lipid levels.Conclusion Irbesartan could attenuate atherosclerosis,and this effect was in part related to inhibition of oxidative stress.
What problem does this paper attempt to address?